Evaluation of the Pharmacokinetics of Felcisetrag (TAK‐954), a 5‐HT <sub>4</sub> Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 Inhibitor-Reference-Cited by-同舟云学术

Evaluation of the Pharmacokinetics of Felcisetrag (TAK‐954), a 5‐HT ₄ Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 Inhibitor

Published:2022-01-06 Issue:2 Volume:11 Page:142-149
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Chen Chunlin¹²,Zhang Liming¹,Almansa Cristina¹³,Rosario Maria¹⁴,Cwik Michael¹,Balani Suresh K.¹,Lock Ruth⁵

Affiliation:

1. Takeda Development Center Americas, Inc. Cambridge Massachusetts USA

2. Bayer Pharmaceuticals Whippany New Jersey USA

3. Ironwood Pharmaceuticals Boston Massachusetts USA

4. Syros Pharmaceuticals Inc Cambridge Massachusetts USA

5. Aucuba Sciences Ltd London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1046

Reference23 articles.

1. Readmissions after colorectal surgery cannot be predicted

2. Hospital Volume, Length of Stay, and Readmission Rates in High-Risk Surgery

3. Postoperative ileus: in search of an international consensus on definition, diagnosis, and treatment

4. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Gastrointestinal Dysfunction Within an Enhanced Recovery Pathway for Elective Colorectal Surgery

5. Alvimopan (Entereg) for the management of postoperative ileus in patients undergoing bowel resection;Kraft M;P T,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards a sustainable tomorrow: advancing green practices in organic chemistry;Green Chemistry;2024

2. The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954);The Journal of Clinical Pharmacology;2022-03-31